Frequency and characteristics of TBII-seronegative patients in a population with untreated Graves' hyperthyroidism: A prospective study

Clinical Endocrinology

Volumn 69, Issue 2, 2008, Pages 311-317

  Vos, Xander G ^a   Smit, Natalie ^a   Endert, Erik ^a   Tijssen, Jan G P ^a   Wiersinga, Wilmar M ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE; THYROTROPIN BINDING INHIBITORY IMMUNOGLOBULIN; THYROTROPIN RECEPTOR; THYROTROPIN RECEPTOR ANTIBODY; THYROXINE;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; ENDOCRINE OPHTHALMOPATHY; ENVIRONMENTAL FACTOR; EVALUATION; FEMALE; GOITER; GRAVES DISEASE; HUMAN; LIOTHYRONINE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MYXEDEMA; OBSERVATIONAL STUDY; POPULATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; THYROID FUNCTION; THYROXINE BLOOD LEVEL;

ADULT; FEMALE; GRAVES DISEASE; HUMANS; HYPERTHYROIDISM; IMMUNOGLOBULINS, THYROID-STIMULATING; MALE; MIDDLE AGED; SEROEPIDEMIOLOGIC STUDIES; THYROID HORMONES;

EID: 47549099245     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2008.03192.x     Document Type: Article

References (32)

1. Brix, T.H., Kyvik, K.O., Christensen, K. Hegedus, L. (2001) Evidence for a major role of heredity in Graves' disease: a population-based study of two Danish twin cohorts. Journal of Clinical Endocrinology and Metabolism, 86, 930 934.
2. Vanderpump, M.P., Tunbridge, W.M., French, J.M., Appleton, D., Bates, D., Clark, F., Grimley, E.J., Hasan, D.M., Rodgers, H. Tunbridge, F. (1995) The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clinical Endocrinology, 43, 55 68.
3. Manji, N., Carr-Smith, J.D., Boelaert, K., Allahabadia, A., Armitage, M., Chatterjee, V.K., Lazarus, J.H., Pearce, S.H.S., Vaidya, B., Gough, S.C. Franklyn, J.A. (2006) Influences of age, gender, smoking, and family history on autoimmune thyroid disease phenotype. Journal of Clinical Endocrinology and Metabolism, 91, 4873 4880.
4. Laurberg, P., Pedersen, K.M., Hreidarsson, A., Sigfusson, N., Iversen, E. Knudsen, P.R. (1998) Iodine intake and the pattern of thyroid disorders: a comparative epidemiological study of thyroid abnormalities in the elderly in Iceland and in Jutland, Denmark. Journal of Clinical Endocrinology and Metabolism, 83, 765 769.
5. Laurberg, P., Nohr, S.B., Pedersen, K.M., Hreidarsson, A.B., Andersen, S., Bulow, P.I., Knudsen, N., Perrild, H., Jorgensen, T. Ovesen, L. (2000) Thyroid disorders in mild iodine deficiency. Thyroid, 10, 951 963.
6. Wiersinga, W.M., Podoba, J., Srbecky, M., van Vessem, M., van Beeren, H.C. Platvoet-Ter Schiphorst, M.C. (2001) A survey of iodine intake and thyroid Volume in Dutch schoolchildren: reference values in an iodine-sufficient area and the effect of puberty. European Journal of Endocrinology, 144, 595 603.
7. Shewring, G. Smith, B.R. (1982) An improved radioreceptor assay for TSH receptor antibodies. Clinical Endocrinology, 17, 409 417.
8. Costagliola, S., Morgenthaler, N.G., Hoermann, R., Badenhoop, K., Struck, J., Freitag, D., Poertl, S., Weglohner, W., Hollidt, J.M., Quadbeck, B., Dumont, J.E., Schumm-Draeger, P.M., Bergmann, A., Mann, K., Vassart, G. Usadel, K.H. (1999) Second generation assay for thyrotropin receptor antibodies has superior diagnostic sensitivity for Graves' disease. Journal of Clinical Endocrinology and Metabolism, 84, 90 97.
9. Massart, C., Hody, B., Mouchel, L., Edan, G. Nicol, M. (1986) Assays for thyrotropin-receptor binding and thyroid-stimulating antibodies in sera from patients with Graves' disease. Clinical Chemistry, 32, 1332 1335.
10. Pedersen, I.B., Knudsen, N., Perrild, H., Ovesen, L. Laurberg, P. (2001) TSH-receptor antibody measurement for differentiation of hyperthyroidism into Graves' disease and multinodular toxic goitre: a comparison of two competitive binding assays. Clinical Endocrinology, 55, 381 390.
11. Paunkovic, J. Paunkovic, N. (2006) Does autoantibody-negative Graves' disease exist? A second evaluation of the clinical diagnosis. Hormone and Metabolic Research, 38, 53 56.
12. Giovanella, L., Ceriani, L. Garancini, S. (2001) Clinical applications of the 2nd generation assay for anti-TSH receptor antibodies in Graves' disease. Evaluation in patients with negative 1st generation test. Clinical Chemistry and Laboratory Medicine, 39, 25 28.
13. Torring, O., Tallstedt, L., Wallin, G., Lundell, G., Ljunggren, J.G., Taube, A., Saaf, M. Hamberger, B. (1996) Graves' hyperthyroidism: treatment with antithyroid drugs, surgery, or radioiodine - a prospective, randomized study. Thyroid Study Group. Journal of Clinical Endocrinology and Metabolism, 81, 2986 2993.
14. Prummel, M.F., Strieder, T. Wiersinga, W.M. (2004) The environment and autoimmune thyroid diseases. European Journal of Endocrinology, 150, 605 618.
15. Perez, C., Scrimshaw, N.S. Munoz, J.A. (1960) Technique of endemic goitre surveys. Monographic Series of World Health Organization, 44, 369 383.
16. Klein, I., Trzepacz, P.T., Roberts, M. Levey, G.S. (1988) Symptom rating scale for assessing hyperthyroidism. Archives of Internal Medicine, 148, 387 390.
17. Wiersinga, W.M. Chopra, I.J. (1982) Radioimmunoassay of thyroxine (T4), 3,5,3′-triiodothyronine (T3), 3,3′,5′-triiodothyronine (reverse T3, rT3), and 3,3′-diiodothyronine (T2). Methods in Enzymology, 84, 272 303.
18. Carella, C., Mazziotti, G., Sorvillo, F., Piscopo, M., Cioffi, M., Pilla, P., Nersita, R., Iorio, S., Amato, G., Braverman, L.E. Roti, E. (2006) Serum thyrotropin receptor antibodies concentrations in patients with Graves' disease before, at the end of methimazole treatment, and after drug withdrawal: evidence that the activity of thyrotropin receptor antibody and/or thyroid response modify during the observation period. Thyroid, 16, 295 302.
19. Maugendre, D. Massart, C. (2001) Clinical value of a new TSH binding inihibitory activity assay using human TSH receptors in the follow-up of antithyroid drug treated Graves' disease. Comparison with thyroid stimulating antibody bioassay. Clinical Endocrinology, 54, 89 96.
20. Schott, M., Feldkamp, J., Bathan, C., Fritzen, R., Scherbaum, W.A. Seissler, J. (2000) Detecting TSH-receptor antibodies with the recombinant TBII assay: technical and clinical evaluation. Hormone and Metabolic Research, 32, 429 435.
21. Villalta, D., Orunesu, E., Tozzoli, R., Montagna, P., Pesce, G., Bizzaro, N. Bagnasco, M. (2004) Analytical and diagnostic accuracy of 'second generation' assays for thyrotrophin receptor antibodies with radioactive and chemiluminescent tracers. Journal of Clinical Pathology, 57, 378 382.
22. Mukuta, T., Tamai, H., Oshima, A., Morita, T., Matsubayashi, S., Fukata, S. Kuma, K. (1994) Immunological findings and thyroid function of untreated Graves' disease patients with undetectable TSH-binding inhibitor immunoglobulin. Clinical Endocrinology, 40, 215 219.
23. Eckstein, A.K., Plicht, M., Lax, H., Neuhauser, M., Mann, K., Lederbogen, S., Heckmann, C., Esser, J. Morgenthaler, N.G. (2006) Thyrotropin receptor autoantibodies are independent risk factors for Graves' ophthalmopathy and help to predict severity and outcome of the disease. Journal of Clinical Endocrinology and Metabolism, 91, 3464 3470.
24. Gerding, M.N., van der Meer, J.W.C., Broenink, M., Bakker, O., Wiersinga, W.M. Prummel, M.F. (2000) Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy. Clinical Endocrinology, 52, 267 271.
25. Khoo, D.H., Ho, S.C., Seah, L.L., Fong, K.S., Tai, E.S., Chee, S.P., Eng, P.H., Aw, S.E. Fok, A.C. (1999) The combination of absent thyroid peroxidase antibodies and high thyroid-stimulating immunoglobulin levels in Graves' disease identifies a group at markedly increased risk of ophthalmopathy. Thyroid, 9, 1175 1180.
26. Noh, J.Y., Hamada, N., Inoue, Y., Abe, Y., Ito, K. Ito, K. (2000) Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease. Thyroid, 10, 809 813.
27. Fatourechi, V. (2005) Pretibial myxedema: pathophysiology and treatment options. American Journal of Clinical Dermatology, 6, 295 309.
28. Stadlmayr, W., Spitzweg, C., Bichlmair, A.M. Heufelder, A.E. (1997) TSH receptor transcripts and TSH receptor-like immunoreactivity in orbital and pretibial fibroblasts of patients with Graves' ophthalmopathy and pretibial myxedema. Thyroid, 7, 3 12.
29. Wu, S.L., Chang, T.C., Chang, T.J., Kuo, Y.F., Hsiao, Y.L. Chang, C.C. (1996) Cloning and sequencing of complete thyrotropin receptor transcripts in pretibial fibroblast culture cells. Journal of Endocrinological Investigations, 19, 365 370.
30. Bitensky, L., aghband-Zadeh, J. Chayen, J. (1974) Studies on thyroid stimulating hormone and the long-acting thyroid stimulating hormone. Clinical Endocrinology, 3, 363 374.
31. Baker, J.R. Jr., Saunders, N.B., Wartofsky, L., Tseng, Y.C. Burman, K.D. (1988) Seronegative Hashimoto thyroiditis with thyroid autoantibody production localized to the thyroid. Annals of Internal Medicine, 108, 26 30.
32. Armengol, M.P., Juan, M., Lucas-Martin, A., Fernandez-Figueras, M.T., Jaraquemada, D., Gallart, T. Pujol-Borrell, R. (2001) Thyroid autoimmune disease: demonstration of thyroid antigen-specific B cells and recombination-activating gene expression in chemokine-containing active intrathyroidal germinal centers. American Journal of Pathology, 159, 861 873.